Vizsgálati helyszín
Texas Retina Associates
Dallas, Texas 75231, Egyesült ÁllamokMég nincs intézményhez kötve
- 12futó vizsgálat
- 14lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 26 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 2. fázis9 vizsgálat
- 3. fázis9 vizsgálat
- 1/2. fázis3 vizsgálat
- 2/3. fázis3 vizsgálat
- 1. fázis1 vizsgálat
- Állapot
- Lezárult11 vizsgálat
- Fut, nem toboroz7 vizsgálat
- Toboroz5 vizsgálat
- Leállították3 vizsgálat
- Fő szponzor
- Aura Biosciences3 vizsgálat
- Hoffmann-La Roche3 vizsgálat
- Apellis Pharmaceuticals, Inc.2 vizsgálat
- Aviceda Therapeutics, Inc.2 vizsgálat
- EyePoint Pharmaceuticals, Inc.2 vizsgálat
- és még 13
Futó vizsgálatok
Toboroz
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
NCT07440225· 2/3. fázis· EyeBiotech Ltd.· Forrás
Contact: Study Coordinator
Fut, nem toboroz
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
NCT07449936· 3. fázis· EyePoint Pharmaceuticals, Inc.· Forrás
Toboroz
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
NCT07215390· 2. fázis· Apellis Pharmaceuticals, Inc.· Forrás
Toboroz
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
NCT06962839· 2. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration
NCT06495918· 3. fázis· Ocular Therapeutix, Inc.· Forrás
Toboroz
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
NCT06541704· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56
NCT06668064· 3. fázis· EyePoint Pharmaceuticals, Inc.· Forrás
Toboroz
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT06635148· 2/3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
NCT06510816· 3. fázis· Annexon, Inc.· Forrás
Fut, nem toboroz
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
NCT06007690· 3. fázis· Aura Biosciences· Forrás
Fut, nem toboroz
Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)
NCT05769153· 1/2. fázis· Alcon Research· Forrás
Fut, nem toboroz
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
NCT03941379· Aura Biosciences· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Leállították
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT06961370· 1. fázis· Hoffmann-La Roche· Forrás
Lezárult
NT-101 Topical Ophthalmic Solution in Patients With Wet AMD
NCT06704009· 1/2. fázis· NexThera Co., Ltd.· Forrás
Leállították
A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
NCT06181227· 2. fázis· Aviceda Therapeutics, Inc.· Forrás
Lezárult
A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
NCT05839041· 2. fázis· Aviceda Therapeutics, Inc.· Forrás
Lezárult
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT05811351· 2. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema
NCT05642312· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
NCT06850922· 1/2. fázis· Genentech, Inc.· Forrás
Lezárult
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
NCT05066997· 2/3. fázis· Oculis· Forrás
Lezárult
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
NCT04777201· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD
NCT04770545· 3. fázis· Apellis Pharmaceuticals, Inc.· Forrás
Lezárult
RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)
NCT04832724· 2. fázis· AbbVie· Forrás
Lezárult
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
NCT04417530· 2. fázis· Aura Biosciences· Forrás
Lezárult
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
NCT04527107· 2. fázis· Oxurion· Forrás
Leállították
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
NCT04437368· 2. fázis· Gyroscope Therapeutics Limited· Forrás
Hibát jelzek